High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements

High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements — Trials · CancerIndex

Clinical trials

Registered studies

44 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 17
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05974085	XPO-1 in Combination With RCHOP for DH/TH Lymphoma	unknown	Phase 2	10	Zhejiang Cancer HospitalOTHER	1	Aug 3, 2023	clinicaltrials
NCT03629873	Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects	unknown	Phase 2	69	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Jan 3, 2022	clinicaltrials